Alcon receives positive recommendation from NICE Appraisal Committee for use of Jetrea® in patients with vitreomacular traction and macular hole

Alcon, the global leader in eye care, is pleased that the National Institute for Health and Care Excellence (NICE) Appraisal Committee has delivered a positive Final Appraisal Determination (FAD) for Jetrea®, recommending its use to treat adults with vitreomacular traction including macular hole of less than or equal to 400 microns when an epiretinal membrane is absent, or… …read more